KTRA News and Press, Kintara Therapeutics Inc Com From 03/13/24

2024-03-13 13:18:36 ET More on Mid-day movers & stocks. Arq, Inc. (ARQ) Q4 2023 Earnings Call Transcript Heron Therapeutics, Inc. 2023 Q4 - Results - Earnings Call Presentation Heron Therapeutics, Inc. (HRTX) Q4 2023 Earnings Call Transcript Heron Therape...

A look at the top 10 most actives in the United States Nikola Corporation (NKLA) fell 4.3% to $0.707999 on volume of 163,563,003 shares PROSHARES TRUST (SQQQ) rose 2.9% to $11.9857 on volume of 127,669,453 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 5.2% to $4.62 on vol...

2024-02-14 16:49:58 ET More on Kintara Therapeutics Financial information for Kintara Therapeutics Read the full article on Seeking Alpha For further details see: Kintara Therapeutics GAAP EPS of -$0.24

Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Update PR Newswire SAN DIEGO , Feb. 14, 2024 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company...

ESSA Pharma Inc. (EPIX) is expected to report $-0.17 for Q1 2024 QuidelOrtho Corp Com (QDEL) is expected to report $2.01 for Q4 2023 FaZe Holdings Inc. (FAZE) is expected to report for Q4 2023 Portsmouth Square, Inc. (PRSI) is expected to report for Q2 2024 Similarweb Ltd. (SMWB) ...

Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer PR Newswire - 15-patient Open Label Study to Confirm Planned Dose and Optimized Study Design Leading to a Phase 3 Clinical Trial in CMBC Patients - ...

2024-01-17 07:30:25 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s time for a breakdown of the biggest pre-market stock movers for Wednesday morning as we check out all of the latest news today! Moving stocks this morning are a canceled dividen...

Kintara Therapeutics Announces Review of Strategic Alternatives PR Newswire - Ladenburg Thalmann Hired as Financial advisor - SAN DIEGO , Dec. 7, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopha...

2023-12-05 09:14:48 ET More on Kintara Therapeutics Kintara slumps on late-stage setback for tumor candidate Seeking Alpha’s Quant Rating on Kintara Therapeutics Historical earnings data for Kintara Therapeutics For further details see: Kintara The...

Kintara Therapeutics Granted Extension by Nasdaq to Regain Compliance with the Stockholders' Equity Continued Listing Requirement PR Newswire SAN DIEGO , Dec. 5, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a bi...